MA51836A - Agents thérapeutiques permettant de traiter le syndrome des jambes sans repos - Google Patents

Agents thérapeutiques permettant de traiter le syndrome des jambes sans repos

Info

Publication number
MA51836A
MA51836A MA051836A MA51836A MA51836A MA 51836 A MA51836 A MA 51836A MA 051836 A MA051836 A MA 051836A MA 51836 A MA51836 A MA 51836A MA 51836 A MA51836 A MA 51836A
Authority
MA
Morocco
Prior art keywords
rest
therapeutic agents
leg syndrome
treat leg
treat
Prior art date
Application number
MA051836A
Other languages
English (en)
Other versions
MA51836B1 (fr
Inventor
Mallory Factor
Michael Strupp
Original Assignee
Intrabio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=65763687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA51836(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intrabio Ltd filed Critical Intrabio Ltd
Publication of MA51836A publication Critical patent/MA51836A/fr
Publication of MA51836B1 publication Critical patent/MA51836B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA51836A 2018-02-15 2019-02-14 Agents thérapeutiques permettant de traiter le syndrome des jambes sans repos MA51836B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862631383P 2018-02-15 2018-02-15
PCT/IB2019/051214 WO2019159110A1 (fr) 2018-02-15 2019-02-14 Agents thérapeutiques permettant de traiter le syndrome des jambes sans repos
EP19710788.1A EP3752141B1 (fr) 2018-02-15 2019-02-14 Acetyl leucine pour le traitement du syndrome des jambes sans repos

Publications (2)

Publication Number Publication Date
MA51836A true MA51836A (fr) 2020-12-23
MA51836B1 MA51836B1 (fr) 2025-01-31

Family

ID=65763687

Family Applications (1)

Application Number Title Priority Date Filing Date
MA51836A MA51836B1 (fr) 2018-02-15 2019-02-14 Agents thérapeutiques permettant de traiter le syndrome des jambes sans repos

Country Status (26)

Country Link
US (1) US11660279B2 (fr)
EP (1) EP3752141B1 (fr)
JP (1) JP7337081B2 (fr)
KR (1) KR102693607B1 (fr)
CN (1) CN111712239A (fr)
AU (1) AU2019221886B2 (fr)
BR (1) BR112020016672A2 (fr)
CA (1) CA3091353A1 (fr)
DK (1) DK3752141T3 (fr)
ES (1) ES2983441T3 (fr)
FI (1) FI3752141T3 (fr)
HR (1) HRP20240925T1 (fr)
HU (1) HUE067240T2 (fr)
IL (1) IL276576B2 (fr)
LT (1) LT3752141T (fr)
MA (1) MA51836B1 (fr)
MD (1) MD3752141T2 (fr)
MX (1) MX2020008504A (fr)
PL (1) PL3752141T3 (fr)
PT (1) PT3752141T (fr)
RS (1) RS65663B1 (fr)
SG (1) SG11202007721YA (fr)
SI (1) SI3752141T1 (fr)
SM (1) SMT202400281T1 (fr)
WO (1) WO2019159110A1 (fr)
ZA (1) ZA202004849B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201709459D0 (en) 2017-06-14 2017-07-26 Intrabio Ltd Treatment for migraine
CN120157593A (zh) 2018-12-06 2025-06-17 内在生物技术有限公司 乙酰基-亮氨酸的氘代类似物
MD3989962T2 (ro) 2019-06-28 2025-12-31 Intrabio Ltd Gb Terapie combinată cu acetil-leucină și miglustat pentru tratamentul unei boli de depozitare lizozomală
WO2021144720A1 (fr) 2020-01-13 2021-07-22 Intrabio Ltd Traitement de maladies neurodégénératives tardives chez des porteurs de mutations hétérozygotes du gène npc1

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2538802C (fr) 2003-09-17 2015-01-27 Xenoport, Inc. Traitement ou prevention du syndrome des jambes sans repos a l'aide de promedicaments a base d'analogues du gaba
RU2458049C2 (ru) 2003-09-17 2012-08-10 Ксенопорт, Инк. Лечение или предупреждение синдрома беспокойных ног с использованием пролекарств аналогов гамк
AU2007235517B2 (en) 2006-04-03 2013-01-31 Teva Pharmaceutical Industries, Ltd. Use of rasagiline for the treatment of Restless Legs Syndrome
TN2010000251A1 (fr) * 2010-06-03 2011-11-11 Rekik Raouf N-acetyl-dl-leucine medicament neuro et retino protecteur
CA2803166C (fr) 2010-06-25 2023-03-07 Shire Human Genetic Therapies, Inc. Administration au snc d'agents therapeutiques
US10045948B2 (en) * 2014-02-27 2018-08-14 Medrx Co., Ltd. Pramipexole-containing transdermal patch for treatment of neurodegenerative disease
TN2019000033A1 (fr) 2016-08-11 2020-07-15 Intrabio Ltd Agents thérapeutiques pour maladies neurodégénératives
GB201709459D0 (en) * 2017-06-14 2017-07-26 Intrabio Ltd Treatment for migraine
US11793782B2 (en) * 2017-10-18 2023-10-24 Intrabio Limited Therapeutic agents for neurodegenerative diseases

Also Published As

Publication number Publication date
HUE067240T2 (hu) 2024-10-28
WO2019159110A1 (fr) 2019-08-22
US20210046031A1 (en) 2021-02-18
AU2019221886B2 (en) 2024-08-08
PL3752141T3 (pl) 2024-08-19
JP2021513977A (ja) 2021-06-03
RU2020130199A (ru) 2022-03-15
MA51836B1 (fr) 2025-01-31
BR112020016672A2 (pt) 2020-12-15
MD3752141T2 (ro) 2024-10-31
MX2020008504A (es) 2020-09-25
KR20200121819A (ko) 2020-10-26
ES2983441T3 (es) 2024-10-23
LT3752141T (lt) 2024-07-10
ZA202004849B (en) 2024-09-25
RU2020130199A3 (fr) 2022-03-31
IL276576A (en) 2020-09-30
US11660279B2 (en) 2023-05-30
CA3091353A1 (fr) 2019-08-22
CN111712239A (zh) 2020-09-25
SI3752141T1 (sl) 2024-09-30
IL276576B1 (en) 2024-06-01
EP3752141A1 (fr) 2020-12-23
SG11202007721YA (en) 2020-09-29
KR102693607B1 (ko) 2024-08-08
IL276576B2 (en) 2024-10-01
JP7337081B2 (ja) 2023-09-01
EP3752141B1 (fr) 2024-06-05
SMT202400281T1 (it) 2024-09-16
PT3752141T (pt) 2024-07-11
RS65663B1 (sr) 2024-07-31
AU2019221886A1 (en) 2020-10-01
HRP20240925T1 (hr) 2024-10-11
FI3752141T3 (fi) 2024-07-02
DK3752141T3 (da) 2024-07-15

Similar Documents

Publication Publication Date Title
IL271085A (en) Bacteria for the treatment of disorders
IL269371A (en) Treatment methods
EP3448263A4 (fr) Traitement électrothérapeutique
EP3757187A4 (fr) Agent de traitement de surface
EP3875139C0 (fr) Traitement des maladies veineuses
EA201790802A1 (ru) Соединения против tnf
EP3846796A4 (fr) Méthodes de traitement du syndrome de libération de cytokine
IL256206A (en) Mct4 inhibitors for treating disease
PL4005570T3 (pl) Pridopidyna do zastosowania w leczeniu zespołu retta
DK4119569T3 (da) Konjugerede antisense-forbindelser til anvendelse i behandling
HUE050944T2 (hu) Kezelési eljárás tradipitant alkalmazásával
SG11201810728UA (en) Leg massager
EP3773633A4 (fr) Méthodes de traitement de glioblastomes
EP3411399A4 (fr) Technologie de synergie anticorps-médicament permettant le traitement de maladies
PL3697399T3 (pl) Środki terapeutyczne do zastosowania w leczeniu zespołu niespokojnych nóg
EP3541931A4 (fr) Traitement combiné fractal
EP3359962A4 (fr) Préparation et profilage sanguins
EP3302695C0 (fr) Dispositifs de traitement des muscles
EP3493821A4 (fr) Méthode de traitement des voies respiratoires
EP3458062A4 (fr) Traitement de la douleur
IT201600105430U1 (it) Letto ribaltabile per persone con disabilità
EP3634494A4 (fr) Thérapies antisens pour le traitement du cancer
MA47502A (fr) Combinaisons pharmaceutiques pour traiter le cancer
EP3606879A4 (fr) Système de traitement des eaux
IL281839A (en) Treatment methods